Samuel Thudium

Samuel Thudium

Auto-generated profile, based on publicly available information

Samuel Thudium

Department of Genetics at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
AAAnja Armache
Anja Armache
SYShuang Yang
Shuang Yang
APAlexia Martínez de Paz
Alexia Martínez de Paz
LRLexi E. Robbins
Lexi E. Robbins
CDCeyda Durmaz
Ceyda Durmaz
SJSteven Z. Josefowicz
Steven Z. Josefowicz

5 October 2022 in Nature
Verified
Journal Article
Closed access
PDF file
JKJohn Kee
John Kee
STSamuel Thudium
Samuel Thudium
DRDavid Michael Renner
David Michael Renner
KGKarl Glastad
Karl Glastad
KPKatherine Palozola
Katherine Palozola
EKErica Korb
Erica Korb

14 September 2022 in Genome Research
Verified
Journal Article
Open access
PDF file
STSamuel Thudium
Samuel Thudium
KPKatherine Palozola
Katherine Palozola
ÉLÉloïse L'HEr
Éloïse L'HEr
EKErica Korb
Erica Korb
Epigenetic regulation plays a critical role in many neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD). In particular, many such disorders are the result of mutations in genes that encode chromatin-modifying proteins. However, although these disorders share many features, it is unclear whether they also share gene expression disruptions resulting from the aberrant regulation of chromatin. We examined five chromatin modifiers that are all linked to ASD despite their different roles in regulating chromatin. Specifically, we depleted ASH1L, CHD8, CREBBP, EHMT1, and NSD1 in parallel in a highly controlled neuronal culture system. We then identified sets of shared genes, or transcriptional signatures, that are differentially expressed following loss of multiple ASD-linked chromatin modifiers. We examined the functions of genes within the transcriptional signatures and found an enrichment in many neurotransmitter transport genes and activity-dependent genes. In addition, these genes are enriched for specific chromatin features such as bivalent domains that allow for highly dynamic regulation of gene expression. The down-regulated transcriptional signature is also observed within multiple mouse models of NDDs that result in ASD, but not those only associated with intellectual disability. Finally, the down-regulated transcriptional signature can distinguish between control and idiopathic ASD patient iPSC-derived neurons as well as postmortem tissue, demonstrating that this gene set is relevant to the human disorder. This work identifies a transcriptional signature that is found within many neurodevelopmental syndromes, helping to elucidate the link between epigenetic regulation and the underlying cellular mechanisms that result in ASD.

6 February 2023 in Nature
Verified
Journal Article
Closed access
JKJohn Kee
John Kee
STSamuel Thudium
Samuel Thudium
DRDavid Michael Renner
David Michael Renner
KGKarl Glastad
Karl Glastad
KPKatherine Palozola
Katherine Palozola
EKErica Korb
Erica Korb

15 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
STSamuel Thudium
Samuel Thudium
KPKatherine Palozola
Katherine Palozola
ELEloise L’her
Eloise L’her
EKErica Korb
Erica Korb
Epigenetic regulation plays a critical role in many neurodevelopmental disorders, including Autism Spectrum Disorder (ASD). In particular, many such disorders are the result of mutations in genes that encode chromatin modifying proteins. However, while these disorders share many features, it is unclear whether they also share gene expression disruptions resulting from the aberrant regulation of chromatin. We examined 5 chromatin modifiers that are all linked to ASD despite their different roles in regulating chromatin. Specifically, we depleted Ash1L, Chd8, Crebbp, Ehmtl, and Nsd1 in parallel in a highly controlled neuronal culture system. We then identified sets of shared genes, or transcriptional signatures, that are differentially expressed following loss of multiple ASD-linked chromatin modifiers. We examined the functions of genes within the transcriptional signatures and found an enrichment in many neurotransmitter transport genes and activity-dependent genes. In addition, these genes are enriched for specific chromatin features such as bivalent domains that allow for highly dynamic regulation of gene expression. The downregulated transcriptional signature is also observed within multiple mouse models of neurodevelopmental disorders that result in ASD, but not those only associated with intellectual disability. Finally, the downregulated transcriptional signature can distinguish between neurons generated from iPSCs derived from healthy donors and idiopathic ASD patients through RNA-deconvolution, demonstrating that this gene set is relevant to the human disorder. This work identifies a transcriptional signature that is found within many neurodevelopmental syndromes, helping to elucidate the link between epigenetic regulation and the underlying cellular mechanisms that result in ASD.

13 January 2021 in Research Square
Verified
Preprint
Open access
PDF file
JKJohn Kee
John Kee
STSamuel Thudium
Samuel Thudium
KGKarl Glastad
Karl Glastad
KPKatherine Palozola
Katherine Palozola
ZZZhen Zhang
Zhen Zhang
EKErica Korb
Erica Korb
SARS-CoV-2 emerged in China at the end of 2019 and caused the global pandemic of COVID-19, a disease with high morbidity and mortality. While our understanding of this novel virus is rapidly increasing, gaps remain in our understanding of how SARS-CoV-2 can effectively suppress host cell antiviral responses. Recent work on other viruses has demonstrated a novel mechanism through which viral proteins can mimic critical regions of human histone proteins. Histone proteins are responsible for governing genome accessibility and their precise regulation is critical for a cell’s ability to control transcription and respond to viral threats. Here, we show that the protein encoded by ORF8 (Orf8) in SARS-CoV-2 functions as a histone mimic of two critical histone 3 sites containing an ARKS motif. Orf8 expression in cells disrupts multiple critical histone post-translational modifications (PTMs) while Orf8 lacking this histone mimic motif does not. Orf8 binds to numerous histone-associated proteins and to DNA, and is itself acetylated within the histone mimic site. Importantly, SARS-CoV-2 infection of multiple susceptible cell types causes the same global changes of histone post-translational modifications that are disrupted by Orf8 expression; these include induced pluripotent stem cell-derived alveolar type 2 cells (iAT2) and cardiomyocytes (iCM) and postmortem patient lung tissue. These findings demonstrate a novel function for the poorly understood SARS-CoV-2 ORF8 encoded protein and a mechanism through which SARS-CoV-2 disrupts host cell epigenetic regulation. Notably, this work provides a potential mechanism for emerging findings from human patients indicating that ORF8 deletion results in less severe illness and describes a potentially druggable pathway that may contribute to the virulence of SARS-CoV-2.